Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry

Miller, Kellee M., Foster, Nicole C., Beck, Roy W., Bergenstal, Richard M., DuBose, Stephanie N., DiMeglio, Linda A., Maahs, David M., Tamborlane, William V.·2015·Diabetes Care

Cited by (1,002)

Items 101–200 of 1,002

  1. The Silver Lining to COVID-19: Avoiding Diabetic Ketoacidosis Admissions with Telehealth
    Anne L. Peters, Satish K. Garg · 2020 · Diabetes Technology & Therapeutics
  2. Cambridge hybrid closed-loop algorithm in children and adolescents with type 1 diabetes: a multicentre 6-month randomised controlled trial
    Julia Ware, Charlotte K. Boughton, Janet M Allen, Malgorzata E. Wilinska, Martin Tauschmann, Louise A Denvir, Ajay Thankamony, Fiona Campbell, Raj Paul Wadwa, Bruce A. Buckingham et al. · 2022 · The Lancet Digital Health
  3. Glycemic Control, Cardiac Autoimmunity, and Long-Term Risk of Cardiovascular Disease in Type 1 Diabetes Mellitus: A DCCT/EDIC Cohort–Based Study
    Sousa, Giovane R., Pober, David, Galderisi, Alfonso, Lv, HuiJuan, Yu, Liping, Pereira, Alexandre C., Doria, Alessandro, Kosiborod, Mikhail, Lipes, Myra A. · 2019 · Circulation
  4. Components of interventions that improve transitions to adult care for adolescents with type 1 diabetes
    Schultz, Alan T., Smaldone, Arlene · 2017 · Journal of Adolescent Health
  5. Patient Demographics and Clinical Outcomes Among Type 1 Diabetes Patients Using Continuous Glucose Monitors: Data From T1D Exchange Real-World Observational Study
    DeSalvo, Daniel J., Noor, Nudrat, Xie, Cicilyn, Corathers, Sarah D., Majidi, Shideh, McDonough, Ryan J., Polsky, Sarit, Izquierdo, Roberto, Rioles, Nicole, Weinstock, Ruth et al. · 2023 · Journal of Diabetes Science and Technology
  6. Ever-Increasing Insulin-Requiring Patients Globally
    Satish K. Garg, Amanda H. Rewers, Halis Kaan Aktürk · 2018 · Diabetes Technology & Therapeutics
  7. Total Pancreatectomy With Islet Autotransplantation Resolves Pain in Young Children With Severe Chronic Pancreatitis
    Melena D. Bellin, Gregory P. Forlenza, Kaustav Majumder, Megan G. Berger, Martin L. Freeman, Gregory J. Beilman, Ty B. Dunn, Timothy L. Pruett, Michael A. Murati, Joshua J. Wilhelm et al. · 2016 · Journal of Pediatric Gastroenterology and Nutrition
  8. The role of structural racism and geographical inequity in diabetes outcomes
    Agarwal, Shivani, Wade, Alisha N, Mbanya, Jean Claude, Yajnik, Chittaranjan, Thomas, Nihal, Egede, Leonard E, Campbell, Jennifer A, Walker, Rebekah J, Maple-Brown, Louise, Graham, Sian · 2023 · The Lancet
  9. Approach to Using Trend Arrows in the FreeStyle Libre Flash Glucose Monitoring Systems in Adults
    Yogish C. Kudva, Andrew Ahmann, Richard M. Bergenstal, James R. Gavin, Davida F. Kruger, L. Kurt Midyett, Eden M Miller, Dennis R. Harris · 2018 · Journal of the Endocrine Society
  10. Feasibility of Continuous Ketone Monitoring in Subcutaneous Tissue Using a Ketone Sensor
    Shridhara Alva, KRISTIN N. CASTORINO, Hyun Cho, Junli Ou · 2021 · Journal of Diabetes Science and Technology
  11. A Review of Insulin Resistance in Type 1 Diabetes: Is There a Place for Adjunctive Metformin?
    Gagan Priya, Sanjay Kalra · 2017 · Diabetes Therapy
  12. A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety data
    Evgenia Gourgari, Erin E. Wilhelm, Hamid Reza Hassanzadeh, Vanita R. Aroda, Ira Shoulson · 2017 · Journal of Diabetes and its Complications
  13. Realizing a Closed-Loop (Artificial Pancreas) System for the Treatment of Type 1 Diabetes
    Rayhan Lal, Laya Ekhlaspour, Korey K. Hood, Bruce A. Buckingham · 2019 · Endocrine Reviews
  14. Islet Encapsulation: Physiological Possibilities and Limitations
    Olle Korsgren · 2017 · Diabetes
  15. Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials
    Giovanni Musso, Roberto Gambino, Maurizio Cassader, Elena Paschetta · 2019 · BMJ
  16. Real-World Use of Do-It-Yourself Artificial Pancreas Systems in Children and Adolescents With Type 1 Diabetes: Online Survey and Analysis of Self-Reported Clinical Outcomes
    Katarina Braune, Shane O’Donnell, Bryan Richard Cleal, Dana Lewis, Adrian Tappe, Ingrid Willaing, Bastian Hauck, Klemens Raile · 2019 · JMIR mhealth and uhealth
  17. Artificial Intelligence in Decision Support Systems for Type 1 Diabetes
    Nichole S. Tyler, Peter G. Jacobs · 2020 · Sensors
  18. Defining Pathways for Development of Disease-Modifying Therapies in Children With Type 1 Diabetes: A Consensus Report
    Diane K. Wherrett, Jane L. Chiang, Alan M. Delamater, Linda Anne DiMeglio, Stephen Eric Gitelman, Peter A. Gottlieb, Kevan C. Herold, Daniel J. Lovell, Trevor John Orchard, Christopher M. Ryan et al. · 2015 · Diabetes Care
  19. Real-World Evidence of Omnipod <sup>®</sup> 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes
    Forlenza, Gregory P., DeSalvo, Daniel J., Aleppo, Grazia, Wilmot, Emma G., Berget, Cari, Huyett, Lauren M., Hadjiyianni, Irene, Méndez, José J., Conroy, Lindsey R., Ly, Trang T. et al. · 2024 · Diabetes Technology &amp; Therapeutics
  20. The efficacy and safety of SGLT2 inhibitors for adjunctive treatment of type 1 diabetes: a systematic review and meta-analysis
    Jiao Chen, Fang Fan, J. Y. Wang, Yang Long, Chenlin Gao, Robert C. Stanton, Yong Xu · 2017 · Scientific Reports
  21. Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial
    Stephen Eric Gitelman, Peter A. Gottlieb, Eric I. Felner, Steven Matthew Willi, Lynda K. Fisher, Antoinette Moran, Michael Everett Gottschalk, Wayne V. Moore, Ashley Pinckney, Lynette Keyes-Elstein et al. · 2016 · Diabetologia
  22. Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting
    Gregory P. Forlenza, Faye M. Cameron, Trang T. Ly, David Wing-Hang Lam, Daniel P. Howsmon, Nihat Baysal, Georgia Kulina, Laurel H. Messer, Paula K. Clinton, Camilla M. Levister et al. · 2018 · Diabetes Technology & Therapeutics
  23. CoYoT1 Clinic: Home Telemedicine Increases Young Adult Engagement in Diabetes Care
    Mark W. Reid, Subramanian Krishnan, Cari Berget, Cindy Cain, John F. Thomas, GEORGEANNA JONES KLINGENSMITH, Jennifer K. Raymond · 2018 · Diabetes Technology & Therapeutics
  24. Faster use and fewer failures with needle-free nasal glucagon versus injectable glucagon in severe hypoglycemia rescue: A simulation study
    Yale, Jean-François, Dulude, Hélène, Egeth, Marc, Piché, Claude A., Lafontaine, Martin, Carballo, Dolorès, Margolies, Rebecca, Dissinger, Emily, Shames, Adam R., Kaplowitz, Nicole et al. · 2017 · Diabetes Technology &amp; Therapeutics
  25. Machine Learning Techniques for Hypoglycemia Prediction: Trends and Challenges
    Omer Mujahid, Iván Contreras, Josep Vehı́ · 2021 · Sensors
  26. Changing the landscape for type 1 diabetes: the first step to prevention
    Dayan, Colin M, Korah, Maria, Tatovic, Danijela, Bundy, Brian N, Herold, Kevan C · 2019 · The Lancet
  27. Improved Accuracy of Continuous Glucose Monitoring Systems in Pediatric Patients with Diabetes Mellitus: Results from Two Studies
    Lori M. Laffel · 2016 · Diabetes Technology & Therapeutics
  28. Twelve-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1c and Hypoglycemia
    Eyal Dassau, Jordan E. Pinsker, Yogish C. Kudva, Sue A. Brown, Ravi Gondhalekar, Chiara Dalla Man, Steve Patek, Michele Schiavon, Vikash Dadlani, Isuru Dasanayake et al. · 2017 · Diabetes Care
  29. The Hybrid Closed-Loop System: Evolution and Practical Applications
    Kathryn W. Weaver, Irl B. Hirsch · 2018 · Diabetes Technology & Therapeutics
  30. The Efficacy of Technology in Type 1 Diabetes: A Systematic Review, Network Meta-analysis, and Narrative Synthesis
    Anthony Pease, Clement Lo, Arul Earnest, Velislava Kiriakova, Danny Liew, Sophia Zoungas · 2020 · Diabetes Technology & Therapeutics
  31. Measures of Glycemic Variability in Type 1 Diabetes and the Effect of Real-Time Continuous Glucose Monitoring
    Ahmed H. El-Laboudi, Ian F. Godsland, Desmond G. Johnston, Nick S. Oliver · 2016 · Diabetes Technology & Therapeutics
  32. Adoption Barriers for Continuous Glucose Monitoring and Their Potential Reduction With a Fully Implanted System: Results From Patient Preference Surveys
    Robert L. Engler, Timothy L. Routh, Joseph Y. Lucisano · 2017 · Clinical Diabetes
  33. Closed-loop control in insulin pumps for type-1 diabetes mellitus: safety and efficacy
    Julia Fuchs, Roman Hovorka · 2020 · Expert Review of Medical Devices
  34. Avoidant coping and diabetes-related distress: Pathways to adolescents’ Type 1 diabetes outcomes.
    Esti Iturralde, Jill A. Weissberg-Benchell, Korey K. Hood · 2016 · Health Psychology
  35. Outpatient 60‐hour day‐and‐night glucose control with dual‐hormone artificial pancreas, single‐hormone artificial pancreas, or sensor‐augmented pump therapy in adults with type 1 diabetes: A n open‐label, randomised, crossover, controlled trial
    Ahmad Haidar, Virginie Messier, Laurent Legault, Martin Ladouceur, RÉMI P.R. RABASA-LHORET · 2017 · Diabetes Obesity and Metabolism
  36. Efficacy and Safety of Resveratrol in Type 1 Diabetes Patients: A Two-Month Preliminary Exploratory Trial
    Ali Movahed, Pema Raj, Iraj Nabipour, Marzieh Mahmoodi, Afshin Ostovar, Mohammadreza Kalantarhormozi, Thomas Netticadan · 2020 · Nutrients
  37. Change in Hemoglobin A1c and Quality of Life with Real-Time Continuous Glucose Monitoring Use by People with Insulin-Treated Diabetes in the Landmark Study
    Timothy R. Gilbert, Adam Noar, Olivia Blalock, William H. Polonsky · 2021 · Diabetes Technology & Therapeutics
  38. Sodium-glucose co-transporter-2 inhibitors as add-on therapy to insulin for type 1 diabetes mellitus: Systematic review and meta-analysis of randomized controlled trials
    Yamada, Tomohide, Shojima, Nobuhiro, Noma, Hisashi, Yamauchi, Toshimasa, Kadowaki, Takashi · 2018 · Diabetes, Obesity and Metabolism
  39. Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Suboptimally Controlled Adolescents With Type 1 Diabetes: A 3-Week, Free-Living, Randomized Crossover Trial
    Martin Tauschmann, Janet M. Allen, Malgorzata E. Wilinska, Hood Thabit, Carlo L. Acerini, David B. Dunger, Roman Hovorka · 2016 · Diabetes Care
  40. Impaired Awareness of Hypoglycemia Continues to be a Risk Factor for Severe Hypoglycemia Despite the Use of Continuous Glucose Monitoring System in Type 1 Diabetes
    Yu Kuei Lin, Man Hung, Anu Rani Sharma, Owen T. M. Chan, Michael Walter Varner, Gitana Staskus, Simon J. Fisher · 2019 · Endocrine Practice
  41. Stress and coping predicts adjustment and glycemic control in adolescents with type 1 diabetes
    Jaser, Sarah S., Patel, Niral, Xu, Meng, Tamborlane, William V., Grey, Margaret · 2017 · Annals of Behavioral Medicine
  42. A randomized, multicentre trial evaluating the efficacy and safety of fast‐acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5)
    David Charles Klonoff, Mark L. Evans, Wendy S. Lane, Hans‐Peter Kempe, Éric Renard, J. Hans DeVries, Tina Graungaard, Agon Hyseni, Theis Gondolf, Tadej Battelino · 2018 · Diabetes Obesity and Metabolism
  43. Long‐term real‐life glycaemic outcomes with a hybrid closed‐loop system compared with sensor‐augmented pump therapy in patients with type 1 diabetes
    Halis Kaan Aktürk, DOMINIQUE A. GIORDANO, Anagha Champakanath, SCOTT J. BRACKETT, Satish K. Garg, Janet K. Snell‐Bergeon · 2019 · Diabetes Obesity and Metabolism
  44. A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System to Manage Children and Adolescents With Diabetes
    Laffel, Lori M, Aleppo, Grazia, Buckingham, Bruce A, Forlenza, Gregory P, Rasbach, Lisa E, Tsalikian, Eva, Weinzimer, Stuart A, Harris, Dennis R · 2017 · Journal of the Endocrine Society
  45. Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials
    Groop, Per-Henrik, Dandona, Paresh, Phillip, Moshe, Gillard, Pieter, Edelman, Steven, Jendle, Johan, Xu, John, Scheerer, Markus F, Thoren, Fredrik, Iqbal, Nayyar et al. · 2020 · The Lancet Diabetes &amp; Endocrinology
  46. Genetically engineered bacterium: Principles, practices, and prospects
    Yiting Liu, Jing Feng, Hangcheng Pan, Xiuwei Zhang, Yunlei Zhang · 2022 · Frontiers in Microbiology
  47. Real-World Use and Self-Reported Health Outcomes of a Patient-Designed Do-it-Yourself Mobile Technology System for Diabetes: Lessons for Mobile Health
    Joyce M. Lee, Mark Newman, Achamyeleh Gebremariam, Preciosa Y. Choi, Dana Michelle Lewis, Weston Nordgren, John Costik, James P. E. Wedding, Benjamin West, Nancy Benovich Gilby et al. · 2017 · Diabetes Technology & Therapeutics
  48. Adjusting insulin doses in patients with type 1 diabetes who use insulin pump and continuous glucose monitoring: Variations among countries and physicians
    Revital Nimri, Eyal Dassau, Tomer Segall, Ido Muller, Nataša Bratina, Olga Kordonouri, Rachel Bello, Torben Biester, Klemen Dovč, Ariel Tenenbaum et al. · 2018 · Diabetes Obesity and Metabolism
  49. SGLT inhibitor adjunct therapy in type 1 diabetes
    Rory J. McCrimmon, Robert R. Henry · 2018 · Diabetologia
  50. Glycemic control and complications in patients with type 1 diabetes - a registry-based longitudinal study of adolescents and young adults
    Siri Carlsen, Torild Skrivarhaug, Geir Thue, John G. Cooper, Lasse G. Gøransson, Karianne Fjeld Løvaas, Sverre Sandberg · 2016 · Pediatric Diabetes
  51. Efficacy of Semaglutide in Overweight and Obese Patients with Type 1 Diabetes
    Garg, Satish K., Kaur, Gurleen, Haider, Zehra, Rodriquez, Erika, Beatson, Christie, Snell-Bergeon, Janet · 2024 · Diabetes Technology &amp; Therapeutics
  52. Psychometric properties of the parent and child problem areas in diabetes measures
    Evans, Meredyth A, Weil, Lindsey E G, Shapiro, Jenna B, Anderson, Lindsay M, Vesco, Anthony T, Rychlik, Karen, Hilliard, Marisa E, Antisdel, Jeanne, Weissberg-Benchell, Jill · 2019 · Journal of Pediatric Psychology
  53. Preventing diabetes distress in adolescents with type 1 diabetes: results 1 year after participation in the STePS Program
    Hood, Korey K., Iturralde, Esti, Rausch, Joseph, Weissberg-Benchell, Jill · 2018 · Diabetes Care
  54. A Patient-Designed Do-It-Yourself Mobile Technology System for Diabetes
    Joyce M. Lee, Emily Hirschfeld, James P. E. Wedding · 2016 · JAMA
  55. Insulin Pump Use in Young Children with Type 1 Diabetes: Sociodemographic Factors and Parent-Reported Barriers
    PERSIS V. COMMISSARIAT, Claire T. Boyle, Kellee M. Miller, Manasa Mantravadi, Daniel J. DeSalvo, William V. Tamborlane, Michelle Anne Van Name, Barbara J. Anderson, Linda Anne DiMeglio, Lori M. Laffel · 2017 · Diabetes Technology & Therapeutics
  56. Is insulin pump therapy effective in Type 1 diabetes?
    John C. Pickup · 2018 · Diabetic Medicine
  57. Closed loop control in adolescents and children during winter sports: Use of the Tandem Control‐IQ AP system
    Laya Ekhlaspour, Gregory P. Forlenza, Daniel R. Cherñavvsky, David M. Maahs, Raj Paul Wadwa, Mark Daniel DeBoer, Laurel H. Messer, Marissa Town, Jennifer Pinnata, Geoff Kruse et al. · 2019 · Pediatric Diabetes
  58. Real-World Use of a New Hybrid Closed Loop Improves Glycemic Control in Youth with Type 1 Diabetes
    Laurel H. Messer, Cari Berget, Laura L. Pyle, Tim Vigers, Erin C. Cobry, Kimberly A. Driscoll, Gregory P. Forlenza · 2021 · Diabetes Technology & Therapeutics
  59. Sleep habits in adolescents with type 1 diabetes: Variability in sleep duration linked with glycemic control
    Niral J Patel, Kimberly L. Savin, Sachini Kahanda, Beth Ann Malow, Lauren A. Williams, Gray Lochbihler, Sarah S. Jaser · 2018 · Pediatric Diabetes
  60. Nanotechnology in cell replacement therapies for type 1 diabetes
    Alexander Ulrich Ernst, Daniel T. Bowers, Long‐Hai Wang, Kaavian Shariati, Mitchell D. Plesser, Natalie K. Brown, Tigran Mehrabyan, Minglin Ma · 2019 · Advanced Drug Delivery Reviews
  61. Diabetes transition care and adverse events: A population-based cohort study in Ontario, Canada
    Shulman, R., Shah, B. R., Fu, L., Chafe, R., Guttmann, A. · 2018 · Diabetic Medicine
  62. Establishment of the T1D Exchange Quality Improvement Collaborative (T1DX-QI)
    Guy Todd Alonso, Sarah Dawn Corathers, Avni C Shah, Mark Allen Clements, Manmohan K. Kamboj, Rona Sonabend, Daniel J. DeSalvo, Sanjeev N. Mehta, ALYSSA B. CABRERA, Nicole A. Rioles et al. · 2020 · Clinical Diabetes
  63. Offline reinforcement learning for safer blood glucose control in people with type 1 diabetes
    Harry Emerson, Matthew Guy, Ryan McConville · 2023 · Journal of Biomedical Informatics
  64. Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin‐pump‐treated patients with type 1 diabetes: The Lira Pump trial—a randomized, double‐blinded, placebo‐controlled trial
    T. Dejgaard, S. Schmidt, C. Frandsen, D. Vistisen, S. Madsbad, H. U. Andersen, K. Nørgaard · 2019 · Diabetes, obesity and metabolism
  65. Insulin Pump Therapy
    Revital Nimri, Judith Nir, Moshe Phillip · 2019 · American Journal of Therapeutics
  66. Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
    Bruce W. Bode, Joseph A. Johnson, Liselotte Hyveled, Soren Can Tamer, Marek Demissie · 2017 · Diabetes Technology & Therapeutics
  67. Dual‐hormone artificial pancreas: benefits and limitations compared with single‐hormone systems
    Tricia M. Peters, Ahmad Haidar · 2018 · Diabetic Medicine
  68. Home Telemedicine (CoYoT1 Clinic): A Novel Approach to Improve Psychosocial Outcomes in Young Adults With Diabetes
    Marwan Bakhach, Mark W. Reid, Elizabeth Ann Pyatak, Cari Berget, Cindy Cain, John F. Thomas, GEORGEANNA JONES KLINGENSMITH, Jennifer K. Raymond · 2019 · The Science of Diabetes Self-Management and Care
  69. Transitioning of people with type 1 diabetes from multiple daily injections and self-monitoring of blood glucose directly to MiniMed 780G advanced hybrid closed-loop system: a two-center, randomized, controlled study
    Matejko, Bartłomiej, Juza, Anna, Kieć-Wilk, Beata, Cyranka, Katarzyna, Krzyżowska, Sabina, Chen, Xiaoxiao, Cohen, Ohad, Da Silva, Julien, Malecki, Maciej T., Klupa, Tomasz · 2022 · Diabetes Care
  70. Continuous Glucose Monitoring (CGM) Adherence in Youth With Type 1 Diabetes: Associations With Biomedical and Psychosocial Variables
    Elisa Giani, Rebecca K. Snelgrove, Lisa K. Volkening, Lori M. Laffel · 2016 · Journal of Diabetes Science and Technology
  71. Continuous Glucose Monitoring Associated With Less Diabetes-Specific Emotional Distress and Lower A1c Among Adolescents With Type 1 Diabetes
    Anthony T. Vesco, Aneta M. Jedraszko, Kimberly P. Garza, Jill A. Weissberg-Benchell · 2018 · Journal of Diabetes Science and Technology
  72. The Diabetes Strengths and Resilience Measure for Adolescents With Type 1 Diabetes (DSTAR-Teen): Validation of a New, Brief Self-Report Measure
    Marisa E. Hilliard, Esti Iturralde, Jill A. Weissberg-Benchell, Korey K. Hood · 2017 · Journal of Pediatric Psychology
  73. Improved A1C Levels in Type 1 Diabetes with Smartphone App Use
    Ryan, Edmond A., Holland, Joanna, Stroulia, Eleni, Bazelli, Blerina, Babwik, Stephanie A., Li, Haipeng, Senior, Peter, Greiner, Russ · 2017 · Canadian Journal of Diabetes
  74. Regulatory T cell therapy for type 1 diabetes: May the force be with you
    Stephen Eric Gitelman, Jeffrey A. Bluestone · 2016 · Journal of Autoimmunity
  75. Levels of type 1 diabetes care in children and adolescents for countries at varying resource levels
    Graham David Ogle, Julia Elisabeth Von Oettingen, Angela Christine Middlehurst, Ragnar Hanås, Trevor John Orchard · 2018 · Pediatric Diabetes
  76. Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 Trial
    Bruce W. Bode, Violeta Iotova, Маргарита Анатольевна Коваренко, Lori M. Laffel, Paturi Vishnupriya Rao, Srikanth Deenadayalan, Magnus Ekelund, Steffen Falgreen Larsen, Thomas Danne · 2019 · Diabetes Care
  77. Effect of Financial Incentives on Glucose Monitoring Adherence and Glycemic Control Among Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial
    Wong, Charlene A., Miller, Victoria A., Murphy, Kathryn, Small, Dylan, Ford, Carol A., Willi, Steven M., Feingold, Jordyn, Morris, Alexander, Ha, Yoonhee P., Zhu, Jingsan et al. · 2017 · JAMA Pediatrics
  78. Monitoring Technologies- Continuous Glucose Monitoring, Mobile Technology, Biomarkers of Glycemic Control
    Nihaal Reddy, Neha Verma, Kathleen Marie Dungan · 2020 · MDText.com, Inc. eBooks
  79. Evaluation of Pump Discontinuation and Associated Factors in the T1D Exchange Clinic Registry
    Wong, Jenise C., Boyle, Claire, DiMeglio, Linda A., Mastrandrea, Lucy D., Abel, Kimber-Lee, Cengiz, Eda, Cemeroglu, Pinar A., Aleppo, Grazia, Largay, Joseph F., Foster, Nicole C. et al. · 2017 · Journal of Diabetes Science and Technology
  80. Practical implementation, education and interpretation guidelines for continuous glucose monitoring: A French position statement
    Sophie Borot, Pierre‐Yves Benhamou, Catherine Atlan, Élise Bismuth, Élisabeth Bonnemaison, Bogdan Catargi, Guillaume Charpentier, Anne Farret, Nathalie Filhol, Sylvia Franc et al. · 2017 · Diabetes & Metabolism
  81. Current Status and Emerging Options for Automated Insulin Delivery Systems
    Gregory P. Forlenza, Rayhan Lal · 2022 · Diabetes Technology & Therapeutics
  82. Glucose control and psychosocial outcomes with use of automated insulin delivery for 12 to 96 weeks in type 1 diabetes: a meta-analysis of randomised controlled trials
    Amanda Godoi, Isabela Reis Marques, Eduardo Messias Hirano Padrão, Ashwin Mahesh, Larissa Calixto Hespanhol, José Eduardo Riceto Loyola Júnior, Isabela A F de Souza, Vittoria Caporal S Moreira, Caroliny Hellen Silva, Isabele Ayumi Miyawaki et al. · 2023 · Diabetology & Metabolic Syndrome
  83. Poor Metabolic Control in Children and Adolescents With Type 1 Diabetes and Psychiatric Comorbidity
    Stine Møller Sildorf, Nina Breinegaard, Emilie Bundgaard Lindkvist, Janne Schurmann Tolstrup, Kirsten Arntz Boisen, Grete Teilmann, Anne Mette Skovgaard, Jannet Svensson · 2018 · Diabetes Care
  84. Techniques for Exercise Preparation and Management in Adults with Type 1 Diabetes
    Jordan E. Pinsker, Amy Kraus, Danielle Gianferante, Benjamen E. Schoenberg, Satbir Singh, Hallie Ortiz, Eyal Dassau, David E. Kerr · 2016 · Canadian Journal of Diabetes
  85. Emerging Treatment Strategies for Diabetes Mellitus and Associated Complications: An Update
    Vijay Kumar Mishra, Pallavi Nayak, Mayank Sharma, Aqel Albutti, Ameen S. S. Alwashmi, Mohammad Abdullah Aljasir, Noorah Alsowayeh, Murtaza M. Tambuwala · 2021 · Pharmaceutics
  86. What End Users and Stakeholders Want From Automated Insulin Delivery Systems
    Diana M. Naranjo, Sakinah Carter Suttiratana, Esti Iturralde, Katharine D. Barnard, Jill A. Weissberg-Benchell, Lori M. Laffel, Korey K. Hood · 2017 · Diabetes Care
  87. Stem cell-derived exosomes: a novel vector for tissue repair and diabetic therapy
    William C Newton, Joseph W Kim, John Z.Q. Luo, LuGuang Luo · 2017 · Journal of Molecular Endocrinology
  88. TCF7L2 Genetic Variants Contribute to Phenotypic Heterogeneity of Type 1 Diabetes
    MARIA JOSE REDONDO, Susan Michelle Geyer, Andrea K. Steck, Jay M. Sosenko, Mark Stuart Anderson, Peter A. Antinozzi, Aaron W. Michels, John M. Wentworth, Ping Xu, Alberto Pugliese et al. · 2017 · Diabetes Care
  89. Outpatient Closed-Loop Control with Unannounced Moderate Exercise in Adolescents Using Zone Model Predictive Control
    Huyett, Lauren M., Ly, Trang T., Forlenza, Gregory P., Reuschel-DiVirgilio, Suzette, Messer, Laurel H., Wadwa, R. Paul, Gondhalekar, Ravi, Doyle, Francis J., Pinsker, Jordan E., Maahs, David M. et al. · 2017 · Diabetes Technology &amp; Therapeutics
  90. Glycemic outcomes with early initiation of continuous glucose monitoring system in recently diagnosed patients with type 1 diabetes
    Mulinacci, Giacomo, Alonso, G. Todd, Snell-Bergeon, Janet K., Shah, Viral N. · 2019 · Diabetes Technology &amp; Therapeutics
  91. An Intervention by a Patient-Designed Do-It-Yourself Mobile Device App Reduces HbA1c in Children and Adolescents with Type 1 Diabetes: A Randomized Double-Crossover Study
    Philippe Klee, Catherine Bussien, Montserrat Castellsague, Christophe Combescure, Mirjam Dirlewanger, Céline M. Girardin, Jean-Luc Mando, Luz Perrenoud, Carole Grasset Salomon, Franck Schneider et al. · 2018 · Diabetes Technology & Therapeutics
  92. CoYoT1 Clinic: Innovative Telemedicine Care Model for Young Adults with Type 1 Diabetes
    Jennifer K. Raymond, Cari Berget, Kimberly A. Driscoll, Kaitlin Ketchum, Cynthia Cain, John F. Thomas · 2016 · Diabetes Technology & Therapeutics
  93. Data, Data Everywhere, and Still Too Hard to Link
    Dmitri Katz, Blaine A. Price, Simon Holland, Nick Sheep Dalton · 2018 · CHI Conference on Human Factors in Computing Systems
  94. Glycaemic variability: The under‐recognized therapeutic target in type 1 diabetes care
    Emma G. Wilmot, Pratik Choudhary, Lalantha Leelarathna, Mike Baxter · 2019 · Diabetes Obesity and Metabolism
  95. A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab
    Chantal Mathieu, ALICE E. WIEDEMAN, Karen M. Cerosaletti, Sarah Alice Long, Elisavet Serti, Laura Cooney, Joan Vermeiren, Silvia Caluwaerts, Karolien Van Huynegem, Lothar Steidler et al. · 2023 · Diabetologia
  96. 20 Years of Pediatric Benchmarking in Germany and Austria: Age-Dependent Analysis of Longitudinal Follow-Up in 63,967 Children and Adolescents with Type 1 Diabetes
    Barbara Bohn, Beate Karges, Christian Vogel, Klaus-Peter Otto, Wolfgang Marg, Sabine E. Hofer, Elke Elisabeth Fröhlich-Reiterer, Martin Holder, Michaela Plamper, Martin Wabitsch et al. · 2016 · PLoS ONE
  97. An Adult Health Care–Based Pediatric to Adult Transition Program for Emerging Adults With Type 1 Diabetes
    Shivani Agarwal, Jennifer K. Raymond, Mark H. Schutta, Serena Cardillo, Victoria A. Miller, Judith A. Long · 2016 · The Science of Diabetes Self-Management and Care
  98. Stable Liquid Glucagon: Beyond Emergency Hypoglycemia Rescue
    Leah M. Wilson, Jessica R. Castle · 2018 · Journal of Diabetes Science and Technology
  99. Gender differences in diabetes self-care in adults with type 1 diabetes: Findings from the T1D Exchange clinic registry
    Viral N. Shah, Mengdi Wu, Sarit Polsky, Janet K. Snell‐Bergeon, Jennifer L. Sherr, Eda Cengiz, Linda Anne DiMeglio, Rodica Pop‐Busui, Kara Mizokami‐Stout, Nicole C. Foster et al. · 2018 · Journal of Diabetes and its Complications
  100. Peptide Immunotherapy for Type 1 Diabetes—Clinical Advances
    Emma Smith, Mark Peakman · 2018 · Frontiers in Immunology